Intracoronary radiation therapy

European Heart Journal

Volumn 22, Issue 8, 2001, Pages 629-647

  Salame, M Y ^a,c   Verheye, S ^a   Crocker, I R ^b   Chronos, N A F ^a   Robinson, K A ^a   King III, S B ^a  

^a Andreas Gruentzig Cardiovasc Center   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Angioplasty; Brachytherapy; Radiation; Restenosis; Thrombosis

Indexed keywords

RADIOISOTOPE;

BETA RADIATION; BRACHYTHERAPY; CARCINOGENESIS; CLINICAL TRIAL; CORONARY STENT; GAMMA RADIATION; HUMAN; IONIZING RADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RESTENOSIS; REVIEW; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; BETA RAYS; BRACHYTHERAPY; CARDIOLOGY; CORONARY DISEASE; DISEASE MODELS, ANIMAL; GAMMA RAYS; HUMANS; PATIENT SELECTION; RADIATION DOSAGE; RADIOGRAPHY, INTERVENTIONAL; RADIOMETRY; RADIOTHERAPY; RECURRENCE; SAFETY; STENTS; TREATMENT OUTCOME;

EID: 0034939154     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2338     Document Type: Review

References (166)

1. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung, and Blood Institute
2. Restenosis after successful percutaneous transluminal coronary angioplasty
3. Restenosis after coronary angioplasty
4. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: A randomized study
5. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty
6. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty
7. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty
8. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty
9. Lack of effect of lovastatin on restenosis after coronary angioplasty
10. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids
11. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty
12. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial
13. Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty
14. Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) trial
15. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial
16. Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis
17. Pharmacologic prevention of restenosis after coronary angioplasty: Review of the randomized clinical trials
18. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy
19. New device angioplasty: The impact on restenosis
20. Directional coronary atherectomy (DCA): A report from the New Approaches to Coronary Intervention (NACI) registry
21. High-speed rotational atherectomy of human coronary stenoses: Acute and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registry
22. Excimer laser coronary angioplasty: The New Approaches to Coronary Intervention (NACI) experience
23. Do excimer laser angioplasty and rotational atherectomy facilitate balloon angioplasty? Implications for lesion-specific coronary intervention
24. Transcatheter device synergy: Use of adjunct directional atherectomy after rotational atherectomy or excimer laser angioplasty
25. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease
26. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery
27. Analysis of late lumen narrowing after excimer laser-facilitated coronary angioplasty
28. Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer Laser, Rotational Atherectomy, and Ballon Angioplasty Comparison (ERBAC) Study
29. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
30. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
31. Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis
32. Vessel size and long-term outcome after coronary stent placement
33. In-stent restenosis: The Washington Hospital Center experience
34. Intravascular radiation for restenosis prevention: Could it be the holy grail?
35. Local catheter-based intracoronary radiation therapy for restenosis
36. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans
37. Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty. A clinical pilot study
38. Catheter-based radiotherapy to inhibit restenosis after coronary stenting
39. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: Results of the beta energy restenosis trial (BERT)
40. Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration
41. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty
42. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia
43. Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: The problem of restenosis
44. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: A necropsy study of 20 patients
45. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization
46. The reparative phenomena at the site of balloon angioplasty in human and experimental models
47. Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistochemical analyses
48. Histopathology of in-stent restenosis in patients with peripheral artery disease
49. Radiation response of human tumors
50. Ueber die strahlentherapie der keloide
51. The role of kilovoltage irradiation in the treatment of keloids
52. Treatment of keloids with surgical excision and postoperative X-ray radiation
53. Heterotopic bone formation after hip surgery: Prevention with single-dose postoperative hip irradiation
54. Prevention of heterotopic bone formation with early post operative irradiation in high risk patients undergoing total hip arthroplasty: Comparison of 10.00 Gy vs 20.00 Gy schedules
55. Management of pterygium with surgery and radiation therapy
56. Postoperative beta radiation treatment of pterygium
57. Cyclic x-ray responses in mammalian cells in vitro
58. Radiosensitivity of vascular tissue. II. Differential radiosensitivity of aortic cells in vitro
59. Effect of hyperlipidemic serum and irradiation on wound healing in primary quiescent cultures of vascular cells
60. Radiation survival properties of cultured vascular smooth muscle cells
61. The validity of Monte Carlo simulation in studies of scattered radiation in diagnostic radiology
62. A Monte Carlo study of the interaction of external beam X-radiation with inhomogeneous media
63. Monte Carlo calculation of the absolute maximum detection efficiency of a cylindrical gamma radiation detector
64. The basic radiobiology of intravascular irradiation
65. Radiation-induced apoptosis
66. Radiation induced apoptosis
67. Radiation-induced apoptosis: Relevance to radiotherapy
68. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
69. Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries
70. Radioactive stents
71. Intracoronary radiation increases apoptosis at 14 days in porcine coronary arteries
72. Intra-arterial 90Y brachytherapy: Preliminary dosimetric study using a specially modified angioplasty balloon
73. The soft X-ray catheter system
74. An experience in treating five hundred and one patients with keloids
75. Role of ionizing irradiation for 393 keloids
76. Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries
77. Dosimetry of a radioactive coronary balloon dilatation catheter for treatment of neointimal hyperplasia
78. Intravascular brachytherapy physics: Review of radiation sources and techniques
79. Distribution of absorbed energy around a point source of beta radiation
80. 186Re-Liquid-filled balloon catheter system for endovascular brachytherapy: Dose-response efficacy study and biodistribution after coronary injection
81. Intracoronary beta radiation after stent implantation in a porcine model
82. Extraction of isotope from a radiance RDX balloon encapsulated thin film source in an arterial flow model
83. Low-dose, beta-particle emission from 'stent' wire results in complete, localized inhibition of smooth muscle cell proliferation
84. Electrodeposition of radioactive rhenium onto stents to prevent restenosis
85. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits
86. Pure beta-particle-emitting stents inhibit neointima formation in rabbits
87. Radiation dose from a phosphorous-32 impregnated wire mesh vascular stent
88. Characterization of a positron emitting V48 nitinol stent for intracoronary brachytherapy
89. Dose distribution for a 32P-impregnated coronary stent: Comparison of theoretical calculations and measurements with radiochromic film
90. Analytic representation of the dose from a 32P-coated stent
91. The dose distribution produced by a 32P-coated stent
92. The antiatherogenic effect of Iridium192 upon the cholesterol-fed rabbit
93. External beam irradiation inhibits neointimal hyperplasia following balloon angioplasty
94. External beam radiation fails to inhibit neointima formation in stented rabbit arteries
95. The effects of low-dose radiation on neointimal hyperplasia
96. Effect of external beam irradiation on neointimal hyperplasia after experimental coronary artery injury
97. Gamma irradiation inhibits neointimal hyperplasia in rats after arterial injury
98. The effect of very low dose irradiation on restenosis following balloon angioplasty. A study in the atherosclerotic rabbit
99. Intimal hyperplasia in an atherosclerotic model: Prevention with radiation therapy
100. Suppression of intimal proliferation with balloon angioplasty with local beta irradiation in rabbits
101. External radiation for restenosis
102. External beam irradiation reduces neointima formation and augments lumen size after coronary stenting in pigs
103. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model
104. Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: Persistent benefit at 6-month follow-up
105. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. A possible role for radiation therapy in restenosis prevention
106. Intracoronary irradiation: Dose response for the prevention of restenosis in swine
107. High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: Angiographic, morphometric, and histopathologic analyses
108. Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries
109. Intraarterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model
110. Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model
111. Intracoronary low-dose beta-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model
112. Inhibition of stent restenosis by beta-emitting Rhenium-188 balloon is dose-dependent and injury-dependent
113. Endovascular radiation with beta and gamma sources in the porcine model
114. Effectiveness of a beta emitting liquid-filled perfusion balloon to prevent restenosis
115. The Guidant intravascular brachytherapy system
116. Radiant liquid isotope intravascular radiation system
117. Edge stenosis after 'low dose' radiation therapy using a Re188 liquid-filled balloon system
118. Endovascular beta radiation in the swine model
119. Inhibition of neointima formation in porcine coronary arteries by Rhenium-186/188 radioactive coil delivered intracoronary after balloon injury
120. Intracoronary delivery of Rhenium-186 radioactive coil after balloon injury inhibits neointima formation in swine coronary arteries
121. Inhibition of neointimal proliferation with low-dose irradiation from a beta-particle-emitting stent
122. Effects of endovascular radiation from a beta-particle-emitting stent in a porcine coronary restenosis model. A dose-response study
123. Low-dose beta-emitting radioactive stents inhibit neointimal hyperplasia in porcine coronary arteries: An IVUS assessment
124. Neointima is reduced but endothelialization is incomplete 3 months after 32P beta-emitting stent placement
125. Long-term results in animals with the radioactive stent
126. Experimental radiation-induced heart disease. I. Light microscopic studies
127. Comparison of endovascular and external beam irradiation in the prevention of restenosis
128. Effects of high-dose intracoronary irradiation on vasomotor function and smooth muscle histopathology
129. The effect of endovascular irradiation on platelet recruitment at sites of balloon angioplasty in pig coronary arteries
130. Endovascular radiation increases thrombosis rate with decreased luminal thrombi and thrombus area
131. Six-month studies with the P32
132. Differential effect of 32P beta particle-emitting stents on the neointima and adventitia in the dog model
133. Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries
134. Three year clinical and angiographic follow-up after intracoronary 192-Iridium radiation therapy
135. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis
136. Radiotherapy to reduce restenosis: Subgroup analysis of the SCRIPPS randomized trial
137. Intracoronary radiation therapy for patients with in-stent restenosis: 6 Month follow-up of a randomized clinical study
138. Localized intracoronary gamma-radiation therapy to inhibit the occurrence of restenosis after stenting
139. Results from the ARTISTIC feasibility study of 192-Iridium gamma radiation to prevent recurrence of in-stent restenosis
140. Restenosis after coronary angioplasty: A multivariate statistical model to relate lesion and procedure variables to restenosis
141. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty
142. Restenosis after successful coronary angioplasty in patients with single-vessel disease
143. Angiographic and clinical outcome following coronary stenting of small vessels: A comparison with coronary stenting of large vessels
144. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty
145. Inhibition of restenosis with beta-emitting radiotherapy. Report of the Proliferation REduction with Vascular Energy Trial (PREVENT)
146. Rhenium 188 liquid filled balloon for the treatment of intracoronary instent restenosis: A 26 patient pilot study
147. Short-term (1 month) results of the IRIS feasibility study of a beta-particle emitting radioisotope stent
148. Short-term (1 month) results of the dose response IRIS feasibility study of a beta-particle emitting radioisotope stent
149. P-32 stents for prevention of restenosis: Results of the Heidelberg safety trial using the Palmaz-Schatz stent design at moderate activity levels in patients with restenosis after PTCA
150. Intravascular ultrasound (IVUS) analysis of beta-particle emitting radioactive stent implantation in human coronary arteries. Preliminary immediate and intermediate-term results of the MILAN study
151. Acute and 30 days results of 32-P beta-particle emitting radioactive stent implantation in patients with CAD - The European experience
152. Results of the Milan BX doseresponse study on 22-P radioactive beta-emitting stent implantation in patients with CAD
153. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study
154. Vascular lesions following radiation
155. Radiation-induced coronary artery disease
156. Rupture of major vessels after radiation
157. Delayed cerebrovascular consequences of therapeutic radiation. A clinicopathologic study of a stroke associated with radiation-related carotid arteriopathy
158. Multistep nature of X-ray-induced neoplastic transformation in mammalian cells: Genetic alterations and instability
159. High-dose radiation and the emergence of thyroid nodular disease
160. Radiation-induced meningioma: With review of literature
161. Soft tissue sarcoma after treatment for breast cancer - A Swedish population-based study
162. Soft tissue sarcoma after treatment for breast cancer
163. Can vascular radiotherapy induce carcinogenesis?
164. Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 24 hours after successful PTCA